Altimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
Provided By Globe Newswire
Last update: Mar 15, 2022
Data readouts from multiple clinical trials expected during the next 6 to 12 months
Strong cash position of $190.3 million as of December 31, 2021
Read more at globenewswire.com4.23
+0.36 (+9.3%)
Find more stocks in the Stock Screener
ALT Latest News and Analysis
5 days ago - ChartmillTop movers in Thursday's sessionLooking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
6 days ago - ChartmillHere are the top movers in Thursday's session.Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
6 days ago - ChartmillGapping stocks in Thursday's sessionToday's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
6 days ago - ChartmillThursday's pre-market session: top gainers and losersBefore the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
